Amylyx Pharmaceuticals, Inc.
Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.
AMLX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US0321085088
- LEI:
- Country:
- United States of America
- Address:
- 43 THORNDIKE STREET, 2141 CAMBRIDGE
- Website:
- https://www.amylyx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company dedicated to discovering and developing novel treatments for neurodegenerative diseases and other conditions with high unmet medical needs. The company advances a pipeline of investigational therapies based on rigorous science and well-defined mechanistic rationale. Key areas of focus in its pipeline include Amyotrophic Lateral Sclerosis (ALS), Wolfram syndrome, and Post-Bariatric Hypoglycemia. Amylyx is committed to a patient-centric approach, aiming to provide solutions for some of medicine's most complex challenges.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Amylyx Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amylyx Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amylyx Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
